Concepedia
Statistics
Publications
69
Citations
6K
H-Index
43
Active since
1991
Affiliations
National Cancer Institute(Current)
Memorial Sloan Kettering Cancer Center
Georgia Regents Medical Center
The University of Texas MD Anderson Cancer Center
National Institutes of Health
Samir N. Khleif is an author at National Cancer Institute specializing in oncology, cancer immunotherapy, and immunotherapy.
Publications per year
1991–2025
Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity.
Samir N. Khleif, James DeGregori, Carole Yee et al. · Proceedings of the National Academy of Sciences · 1996 · 361 citations
Life Sciences, Cell Biology, Oncology +17
Randomized Phase II Trial of Nivolumab Versus Nivolumab and Ipilimumab for Recurrent or Persistent Ovarian Cancer: An NRG Oncology Study
Dmitriy Zamarin, Robert A. Burger, Michael W. Sill et al. · Journal of Clinical Oncology · 2020 · 351 citations · Full text
Pharmacy, Oncology, Pharmacotherapy +16
PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance
Vivek Verma, Rajeev Shrimali, Shamim Ahmad et al. · Nature Immunology · 2019 · 333 citations · Full text
Life Sciences, Immunology, Oncology +17
CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16INK4 protein induction by 5-aza 2'deoxycytidine.
Gregory A. Otterson, Samir N. Khleif, Wei Chen et al. · PubMed · 1995 · 216 citations
Medicine, Molecular Biology, Molecular Genetics +13
AACR-FDA-NCI Cancer Biomarkers Collaborative Consensus Report: Advancing the Use of Biomarkers in Cancer Drug Development
Samir N. Khleif, James H. Doroshow, William N. Hait · Clinical Cancer Research · 2010 · 186 citations
Pharmacy, Cancer Biology, Oncology +16
1–5 of 69